Trial
NCT03872505
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
AstraZeneca
Condition
Breast Cancer
Intervention
Durvalumab
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-25